Gefitinib Impurity VIII | CAS 788136-89-0 - Request Quote
Gefitinib Impurity VIII
| SZ CAT No: | SZ-G018017 |
| CAS No | 788136-89-0 |
| Mol.F. | C17H13ClFN3O3 |
| Mol.Wt. | 361.8 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Gefitinib Impurity VIII is chemically 4-((3-Chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl acetate. Gefitinib Impurity VIII is supplied with detailed characterization data compliant with regulatory guideline. Gefitinib Impurity VIII can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Gefitinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 788136-89-0
Purchase 788136-89-0
Order 788136-89-0
Enquire 788136-89-0
price of 788136-89-0
788136-89-0 Supplier
788136-89-0 Manufacturer
788136-89-0 Exporter
buy high quality Gefitinib Impurity VIII
Purchase Gefitinib Impurity VIII
Gefitinib Impurity VIII suppliers
Gefitinib Impurity VIII manufacturers
Gefitinib Impurity VIII price
Order Gefitinib Impurity VIII
Enquire Gefitinib Impurity VIII
Gefitinib Impurity VIII cost
Gefitinib Impurity VIII Supplier
Gefitinib Impurity VIII Distributor
Gefitinib Impurity VIII for Method Validation
Gefitinib Reference Standard
Gefitinib Impurity VIII for ANDA Filing
Gefitinib Impurity VIII for Forced Degradation Studies
Gefitinib Impurity VIII Identification Standards
Gefitinib Impurity VIII for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.